APA (7th ed.) Citation

Wakayama, S., Ouchi, K., Takahashi, S., Yamada, Y., Komatsu, Y., Shimada, K., . . . Ishioka, C. (2023). TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer. Clinical colorectal cancer, 22(3), 327-338. https://doi.org/10.1016/j.clcc.2023.06.001

Chicago Style (17th ed.) Citation

Wakayama, Shonosuke, et al. "TP53 Gain-of-Function Mutation Is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer." Clinical Colorectal Cancer 22, no. 3 (2023): 327-338. https://doi.org/10.1016/j.clcc.2023.06.001.

MLA (9th ed.) Citation

Wakayama, Shonosuke, et al. "TP53 Gain-of-Function Mutation Is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer." Clinical Colorectal Cancer, vol. 22, no. 3, 2023, pp. 327-338, https://doi.org/10.1016/j.clcc.2023.06.001.